NIDA Director Says Evidence Exists Showing Cannabis Prohibition’s Racist Effects

September 14, 2021 04:25:40

Decades after the government kicked off the war on drugs in an attempt to reduce drug abuse and defund the criminal enterprises behind the drug trade, America is still reeling from the effects of this failed endeavor. While the intent behind the drug war was noble, authorities went about achieving it the wrong way, mainly focusing their attention on minorities such as African Americans and Latinos, and wreaking untold havoc on these underserved communities.

Presently, it is widely accepted that the decades-long war on drugs is an unmitigated failure that has ruined millions of lives over exceedingly minor drug offenses, broken families and condemned people to generations of poverty.

According to a prominent federal official, it is so apparent that the drug war has had a disproportionate effect on communities of color that there is no need for further research on the matter. The National Institute on Drug Abuse’s Director N. Volkow has frequently made her thoughts on the wide-ranging effects of the war on drugs known, stating repeatedly that the country needs to stop looking at drug abuse as a criminal issue and start approaching it as a matter of public health. In a new interview with “Springer Nature,” a scientific journal publication, Volkow again discussed the effects of drug criminalization as well as America’s approach to drug addiction.

Volkow, who recently wrote an op-ed for the popular media outlet Scientific American, said that minority communities were unfairly targeted by the drug war, leading to intense policing and harsh sentences, and that is reason enough to re-evaluate America’s drug policies. The long history of racist as well as discriminatory policies continues today, she says, and imprisoning people of color at a disproportionately high rate has had catastrophic effects on the minority communities’ families, health, education, housing, and economic security as well as mobility. There is more than enough solid evidence to prove this, she says, and what we need to do now is to have an urgent discussion on how to change these drug policies.

When she was asked about America’s approach to substance misuse and whether there was consensus on the necessity to change the country’s strategy, she said “serious work” is required. Drug use, addiction and mental disorders are extremely stigmatized in societies across the world, she says, and it is only natural for humans to fear and alienate what they consider taboo.

However, this means that drug addiction as well as mental disorders are often treated as a criminal issue instead of tackling them with “evidence-backed care plus compassion” as a public health matter, she noted. Ultimately, America needs to reconsider how it addresses drug use and abuse.

Research enabling tools, such as the IoT dose-measuring devices made by companies such as  RYAH Group Inc. (CSE: RYAH) have the potential to make obtaining accurate and reliable scientific data during trials easier.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published:

Do you have questions or are you interested in working with CNW420? Ask our Editor

Denver, Colorado
303.498.7722 Office

CNW420 is part of the InvestorBrandNetwork.